Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score
We evaluated the joint relationship of post-operative C-reactive protein (poCRP) and a tumor immune-cell-score (IS) with overall survival (OS) and CRC-specific survival (CSS) in 680 colorectal cancer (CRC) patients recruited in Germany. CRP was assessed post-surgery while IS was derived from CD3 + /...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 November 2025
|
| In: |
npj precision oncology
Year: 2025, Jahrgang: 9, Heft: 1, Pages: 1-7 |
| ISSN: | 2397-768X |
| DOI: | 10.1038/s41698-025-01192-1 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41698-025-01192-1 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41698-025-01192-1 
|
| Verfasserangaben: | Tafirenyika Gwenzi, Durgesh Wankhede, Tanwei Yuan, Megha Bhardwaj, Petra Schrotz-King, Sophie C. Anker, Ben Schöttker, Michael Hoffmeister and Hermann Brenner |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1963303326 | ||
| 003 | DE-627 | ||
| 005 | 20260303123555.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260303s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41698-025-01192-1 |2 doi | |
| 035 | |a (DE-627)1963303326 | ||
| 035 | |a (DE-599)KXP1963303326 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gwenzi, Tafirenyika |d 1983- |e VerfasserIn |0 (DE-588)1297870115 |0 (DE-627)1854049690 |4 aut | |
| 245 | 1 | 0 | |a Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score |c Tafirenyika Gwenzi, Durgesh Wankhede, Tanwei Yuan, Megha Bhardwaj, Petra Schrotz-King, Sophie C. Anker, Ben Schöttker, Michael Hoffmeister and Hermann Brenner |
| 264 | 1 | |c 25 November 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.03.2026 | ||
| 520 | |a We evaluated the joint relationship of post-operative C-reactive protein (poCRP) and a tumor immune-cell-score (IS) with overall survival (OS) and CRC-specific survival (CSS) in 680 colorectal cancer (CRC) patients recruited in Germany. CRP was assessed post-surgery while IS was derived from CD3 + /CD8+ cell densities in tumor tissue. Patients were categorized into four C-Reactive protein-Immune cell Score (CRIS) groups: CRIS-1 (CRP-low/IS-high), CRIS-2 (CRP-low/IS-low), CRIS-3 (CRP-high/IS-high), and CRIS-4 (CRP-high/IS-low). Associations of CRIS with survival were assessed using Cox regression, and quantified by hazard ratios with 95% confidence intervals (HR, 95%CI). Subgroup analysis by presence of non-metastatic disease and time of blood draw in relation to adjuvant chemotherapy were conducted. After a median follow-up of 9.6 (IQR, 4.6-14.6) years, 214 (31.5%) patients died, 140 (20.6%) from CRC. Patients in CRIS-4 category had worse prognosis compared to CRIS-1 category [HR(95%CI): 2.01 (1.32-3.08) and 2.60 (1.57-4.32) for OS and CSS, respectively]. These associations were stronger for non-metastatic disease (OSHR = 2.45, CSSHR = 4.49), as well as for patients with blood collected after adjuvant chemotherapy (OSHR = 4.17, CSSHR = 6.62). Integrating post-operative systemic inflammation and tumor immune characteristics may improve prognostic stratification of patients receiving adjuvant chemotherapy for non-metastatic CRC. | ||
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Gastroenterology | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Oncology | |
| 700 | 1 | |a Wankhede, Durgesh |e VerfasserIn |0 (DE-588)135353314X |0 (DE-627)1914903188 |4 aut | |
| 700 | 1 | |a Yuan, Tanwei |d 1995- |e VerfasserIn |0 (DE-588)1299871909 |0 (DE-627)1857588649 |4 aut | |
| 700 | 1 | |a Bhardwaj, Megha |d 1985- |e VerfasserIn |0 (DE-588)1147332606 |0 (DE-627)1006074554 |0 (DE-576)495748021 |4 aut | |
| 700 | 1 | |a Schrotz-King, Petra |e VerfasserIn |0 (DE-588)1078258066 |0 (DE-627)838209327 |0 (DE-576)450367118 |4 aut | |
| 700 | 1 | |a Anker, Sophie |d 1990- |e VerfasserIn |0 (DE-588)1205326065 |0 (DE-627)169090965X |4 aut | |
| 700 | 1 | |a Schöttker, Ben |e VerfasserIn |0 (DE-588)138862443 |0 (DE-627)703132423 |0 (DE-576)309375657 |4 aut | |
| 700 | 1 | |a Hoffmeister, Michael |d 1973- |e VerfasserIn |0 (DE-588)134103726 |0 (DE-627)560880820 |0 (DE-576)277089565 |4 aut | |
| 700 | 1 | |a Brenner, Hermann |e VerfasserIn |0 (DE-588)1020516445 |0 (DE-627)691247005 |0 (DE-576)360642136 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t npj precision oncology |d [London] : Springer Nature, 2017 |g 9(2025), 1, Artikel-ID 386, Seite 1-7 |h Online-Ressource |w (DE-627)884384454 |w (DE-600)2891458-2 |w (DE-576)486547728 |x 2397-768X |7 nnas |a Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score |
| 773 | 1 | 8 | |g volume:9 |g year:2025 |g number:1 |g elocationid:386 |g pages:1-7 |g extent:7 |a Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41698-025-01192-1 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41698-025-01192-1 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260303 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1020516445 |a Brenner, Hermann |m 1020516445:Brenner, Hermann |d 50000 |e 50000PB1020516445 |k 0/50000/ |p 9 |y j | ||
| 998 | |g 134103726 |a Hoffmeister, Michael |m 134103726:Hoffmeister, Michael |d 50000 |e 50000PH134103726 |k 0/50000/ |p 8 | ||
| 998 | |g 138862443 |a Schöttker, Ben |m 138862443:Schöttker, Ben |d 50000 |e 50000PS138862443 |k 0/50000/ |p 7 | ||
| 998 | |g 1205326065 |a Anker, Sophie |m 1205326065:Anker, Sophie |d 910000 |d 910100 |e 910000PA1205326065 |e 910100PA1205326065 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1078258066 |a Schrotz-King, Petra |m 1078258066:Schrotz-King, Petra |d 50000 |e 50000PS1078258066 |k 0/50000/ |p 5 | ||
| 998 | |g 1147332606 |a Bhardwaj, Megha |m 1147332606:Bhardwaj, Megha |d 50000 |e 50000PB1147332606 |k 0/50000/ |p 4 | ||
| 998 | |g 1299871909 |a Yuan, Tanwei |m 1299871909:Yuan, Tanwei |d 50000 |e 50000PY1299871909 |k 0/50000/ |p 3 | ||
| 998 | |g 135353314X |a Wankhede, Durgesh |m 135353314X:Wankhede, Durgesh |d 50000 |e 50000PW135353314X |k 0/50000/ |p 2 | ||
| 998 | |g 1297870115 |a Gwenzi, Tafirenyika |m 1297870115:Gwenzi, Tafirenyika |d 910000 |d 950000 |d 950950 |e 910000PG1297870115 |e 950000PG1297870115 |e 950950PG1297870115 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950950/ |p 1 |x j | ||
| 999 | |a KXP-PPN1963303326 |e 492747643X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Gwenzi","display":"Gwenzi, Tafirenyika","role":"aut","given":"Tafirenyika"},{"role":"aut","display":"Wankhede, Durgesh","given":"Durgesh","family":"Wankhede"},{"given":"Tanwei","role":"aut","display":"Yuan, Tanwei","family":"Yuan"},{"given":"Megha","role":"aut","display":"Bhardwaj, Megha","family":"Bhardwaj"},{"role":"aut","display":"Schrotz-King, Petra","given":"Petra","family":"Schrotz-King"},{"display":"Anker, Sophie","role":"aut","given":"Sophie","family":"Anker"},{"family":"Schöttker","display":"Schöttker, Ben","role":"aut","given":"Ben"},{"family":"Hoffmeister","given":"Michael","role":"aut","display":"Hoffmeister, Michael"},{"family":"Brenner","display":"Brenner, Hermann","role":"aut","given":"Hermann"}],"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}],"title":[{"title_sort":"Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score","title":"Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"25 November 2025"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"name":{"displayForm":["published by Springer Nature in partnership with The Hormel Institute, University of Minnesota"]},"titleAlt":[{"title":"a nature research journal"},{"title":"Precision oncology"}],"origin":[{"publisher":"Springer Nature","publisherPlace":"[London]","dateIssuedDisp":"[2017]-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"npj precision oncology","subtitle":"a natureresearch journal","title_sort":"npj precision oncology"}],"language":["eng"],"note":["Gesehen am 20. April 2017"],"id":{"zdb":["2891458-2"],"issn":["2397-768X"],"eki":["884384454"]},"recId":"884384454","disp":"Predicting colorectal cancer survival by combined c-reactive protein and tumor immune scorenpj precision oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["20 March 2017-"],"part":{"extent":"7","text":"9(2025), 1, Artikel-ID 386, Seite 1-7","volume":"9","pages":"1-7","issue":"1","year":"2025"}}],"note":["Gesehen am 03.03.2026"],"name":{"displayForm":["Tafirenyika Gwenzi, Durgesh Wankhede, Tanwei Yuan, Megha Bhardwaj, Petra Schrotz-King, Sophie C. Anker, Ben Schöttker, Michael Hoffmeister and Hermann Brenner"]},"recId":"1963303326","id":{"doi":["10.1038/s41698-025-01192-1"],"eki":["1963303326"]}} | ||
| SRT | |a GWENZITAFIPREDICTING2520 | ||